Lanadelumab
Records for this ingredient, by country (identity only).
ATC B06AC05 · 11 markets · 29 records
AU 5 records · 3 shown of 3
- 300 mg/2 mLinjectionTAKHZYRO
- 300 mg per mL / per unit basis not statedinjectionTAKHZYRO lanadelumab 300 mg/2 mL solution for injection pre-filled syringeTAKHZYRO lanadelumab 300mg/2mL solution for injection vial
- 150 mg per mL / per unit basis not statedinjectionTAKHZYRO lanadelumab 300 mg/2 mL solution for injection pre-filled syringe
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
GB 4 records · 2 shown of 2
- 300 mg/2 mLinjectionTakhzyro 300mg/2ml solution for injection pre-filled pensTakhzyro 300mg/2ml solution for injection pre-filled syringes、Takhzyro 300mg/2ml solution for injection vials
- 150 mg/1 mLinjectionTakhzyro 300mg/2ml solution for injection pre-filled syringes
CA 4 records · 2 shown of 2
US 3 records · 3 shown of 3
FR 3 records · 2 shown of 2
- 300 mg/2 mLinjectionTAKHZYRO 150 mg, solution injectable en seringue préremplieTAKHZYRO 300 mg, solution injectable
- 150 mg/1 mLinjectionTAKHZYRO 150 mg, solution injectable en seringue préremplie
SG 2 records · 2 shown of 2
- 300 mg/2 mLinjectionTAKHZYRO SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 300MG/2ML
- 150 mg/mL per mL / per unit basis not statedinjectionTAKHZYRO SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 150MG/ML
ES 2 records · 2 shown of 2
- 300 mg per mL / per unit basis not statedinjectionTAKHZYRO PRECARGADA
- 150 mg per mL / per unit basis not statedinjectionTAKHZYRO PRECARGADA
JP 2 records · 1 shown of 1
- 300 mg/2 mLinjectionタクザイロ皮下注300mgシリンジタクザイロ皮下注300mgペン
TW 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
HK 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
EU 1 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
| Strength / form / release | US | GB | CA | AU | SG | ES | TW | HK | JP | EU | FR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300 mg/2 mL injection | Takhzyro 300mg/2ml solution for injection pre-filled pens Takhzyro 300mg/2ml solution for injection pre-filled syringes Takhzyro 300mg/2ml solution for injection vials | TAKHZYRO | TAKHZYRO SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 300MG/2ML | タクザイロ皮下注300mgシリンジ タクザイロ皮下注300mgペン | TAKHZYRO 150 mg, solution injectable en seringue préremplie TAKHZYRO 300 mg, solution injectable | ||||||
| 300 mg per mL / per unit basis not stated cannot compare injection | TAKHZYRO lanadelumab 300 mg/2 mL solution for injection pre-filled syringe TAKHZYRO lanadelumab 300mg/2mL solution for injection vial | TAKHZYRO PRECARGADA | |||||||||
| 150 mg per mL / per unit basis not stated cannot compare liquid | TAKHZYRO | TAKHZYRO | |||||||||
| 150 mg/1 mL injection | Takhzyro 300mg/2ml solution for injection pre-filled syringes | TAKHZYRO 150 mg, solution injectable en seringue préremplie | |||||||||
| 150 mg per mL / per unit basis not stated cannot compare injection | TAKHZYRO lanadelumab 300 mg/2 mL solution for injection pre-filled syringe | TAKHZYRO PRECARGADA | |||||||||
| 300 mg/2 mL liquid | TAKHZYRO | ||||||||||
| 150 mg/1 mL liquid | TAKHZYRO | ||||||||||
| 300 mg/2.25 mL injection | Manufacturer: Catalent Indiana, LLC | ||||||||||
| 150 mg/mL per mL / per unit basis not stated cannot compare injection | TAKHZYRO SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 150MG/ML | ||||||||||
unknown | Takhzyro PFS | TAKHZYRO SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 300MG/2ML | TAKHZYRO | ||||||||
injection | Takhzyro solution for 得釋腫注射劑 |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
3 more strength/form rows are recorded only in CA · SG · TW and are not shown in this table. Hay 3 filas de concentración/forma registradas solo en CA · SG · TW que no se muestran en esta tabla. 另有 3 个规格/剂型仅在 CA · SG · TW 有记录（未在本表显示）。 另有 3 個規格/劑型僅在 CA · SG · TW 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.